Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Muggia

Showing results (131-140 of 424) with videos related to

Pageof 43
Sort By:
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1980
Clinical implications of cisplatin pharmacologyF M Muggia, M Rozencweig, J Penta
Cancer Clinical Trials|January 1, 1979
International activities of the Division of Cancer Treatment, National Cancer InstituteA Goldin, F M Muggia, M Rozencweig
The American Journal of Medicine|July 1, 1987
Carcinoid syndrome from a tumor of Meckel's diverticulumM Green, R Oratz, F M Muggia
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 25, 2014
The effect of germ-line BRCA mutations on response to chemotherapy and outcome of recurrent ovarian cancerTamar Safra, Ori Rogowski, Franco M Muggia
Injury|January 1, 1982
A bipedicled chest wall flap to cover an open elbow joint in a burned infantK Abu-Dalu, M Muggia, M Schiller
Diseases of the Colon and Rectum|October 1, 1982
Factors affecting the morbidity of colostomy closure: a retrospective studyH R Freund, J Raniel, M Muggia-Sulam
Anticancer Research|March 1, 1987
Characterization of conditions in which dipyridamole enhances methotrexate toxicity in L1210 cellsF M Muggia, P Slowiaczek, M H Tattersall
Cancer Treatment Reviews|November 1, 1996
Second-look laparotomy for stage III epithelial ovarian cancer: rationale and current issuesL Muderspach, F M Muggia, P S Conti
Cancer Treatment Reports|September 1, 1977
Current cooperative clinical trials in the non-Hodgkin's lymphomasF M Muggia, H L Davis, M Rozencweig
Cancer Research|March 1, 1986
Synergistic activity of doxorubicin and the bisdioxopiperazine (+)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane (ICRF 187) against the murine sarcoma S180 cell lineS Wadler, M D Green, F M Muggia
Pageof 43

Showing results (131-140 of 424) with videos related to

Sort By:
Pageof 43
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1980
Clinical implications of cisplatin pharmacologyF M Muggia, M Rozencweig, J Penta
Cancer Clinical Trials|January 1, 1979
International activities of the Division of Cancer Treatment, National Cancer InstituteA Goldin, F M Muggia, M Rozencweig
The American Journal of Medicine|July 1, 1987
Carcinoid syndrome from a tumor of Meckel's diverticulumM Green, R Oratz, F M Muggia
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 25, 2014
The effect of germ-line BRCA mutations on response to chemotherapy and outcome of recurrent ovarian cancerTamar Safra, Ori Rogowski, Franco M Muggia
Injury|January 1, 1982
A bipedicled chest wall flap to cover an open elbow joint in a burned infantK Abu-Dalu, M Muggia, M Schiller
Diseases of the Colon and Rectum|October 1, 1982
Factors affecting the morbidity of colostomy closure: a retrospective studyH R Freund, J Raniel, M Muggia-Sulam
Anticancer Research|March 1, 1987
Characterization of conditions in which dipyridamole enhances methotrexate toxicity in L1210 cellsF M Muggia, P Slowiaczek, M H Tattersall
Cancer Treatment Reviews|November 1, 1996
Second-look laparotomy for stage III epithelial ovarian cancer: rationale and current issuesL Muderspach, F M Muggia, P S Conti
Cancer Treatment Reports|September 1, 1977
Current cooperative clinical trials in the non-Hodgkin's lymphomasF M Muggia, H L Davis, M Rozencweig
Cancer Research|March 1, 1986
Synergistic activity of doxorubicin and the bisdioxopiperazine (+)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane (ICRF 187) against the murine sarcoma S180 cell lineS Wadler, M D Green, F M Muggia
Pageof 43